Consistent with previous study that the combination of DNMTis and PARPis could increase PARP trapping 46, we also observed that the combination treatment in CCA cells increased the trapping of toxic PARP (Figure 6D). The gene discussed is PARP1; the disease is cholangiocarcinoma.